Rule 64B16-28.108 related to labeling of Medicinal Drugs by pharmacy permits has been revised by the Board of Pharmacy and became effective November 28, 2021. The revision is primarily for Institutional Class II, Modified Class II Type B, or Class III permits that are labeling patient specific medications.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.